We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Vernalis | LSE:VER | London | Ordinary Share | GB00B3Y5L754 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6.17 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
29/7/2013 16:31 | And another buyer comes in with an increased holding. Sign of future action on the M&A front? Fellner ALWAYS a consummate deal maker! | fhmktg | |
29/7/2013 08:58 | Fly? Everythings relative, but any re-awakening of interest in Vernalis as a growth company would be welcomed. Certainly the basis for a successful portfolio is there- but I'm not sure I will be around to see the full benefit. The incresed holdings announced Friday could be the first shoots of interest showing through. sic gloria transit British Biotech! | fhmktg | |
29/7/2013 07:27 | Very good results out today. This is ready to FLY imho. DYOR | hvs | |
27/7/2013 22:16 | Three RNS announcements of increased institutional buying to above notifying levels. Very promising! | fhmktg | |
24/7/2013 16:07 | 82m traded... any ideas | latifs100 | |
12/7/2013 14:31 | ref 1211, just found the following paper: Results of trial for Frova plus Dexketoprofen for PMS migraine- perhaps this is where the fight back from the previous FDA dissappointment begins! | fhmktg | |
12/7/2013 14:23 | Another (small) brick in the wall with the trial for V81444- interestingly the trial is on volunteer patients with existing symptoms. Proof of concept by year end? | fhmktg | |
29/6/2013 15:10 | British Biotech ? - it was all smoke and mirrors at the time we need solid progress - some hope given in Shares - 2017 a long shot | jarbie | |
13/6/2013 08:16 | Wonder if today's announcement indicates there may be some extended life or extension of scope for Frova? Shame it never took off for PMT! Dexketoprofen is made by Menarini so presumably they have identified the combination with Frova as a promising area. Licensed throughout the world so approvals not needed. This might help penetration into the US? | fhmktg | |
10/4/2013 08:57 | Good report - re-building of the company continues apace. Transformational year on the way both on licenced products and potential pipeline. Keep the faith, maybe British Biotech can rise from the ashes! | fhmktg | |
13/3/2013 11:15 | very quiet here. added | mrsapeslaptop | |
06/3/2013 14:58 | Slowly, slowly a 'New' Future for Vernalis is taking shape! | fhmktg | |
07/2/2013 12:36 | Theres been no trades | knigel | |
07/2/2013 12:32 | and again. think its stirring | mrsapeslaptop | |
04/2/2013 08:24 | Good boys - that will help pay the bills! | fhmktg | |
30/1/2013 12:57 | some nice volume and a little rise. | mrsapeslaptop | |
02/1/2013 20:33 | even with good news this still stagnates at a low price. Its going to take years to get this past £1. | 4screws | |
02/1/2013 11:20 | Im in. hello all | mrsapeslaptop | |
12/12/2012 07:55 | RNS-This could be the start of something big! | fhmktg | |
20/9/2012 12:06 | Another few bob in the bank - good collaboration this! | fhmktg | |
12/9/2012 15:06 | 4screws - the real question is - why is it doing so well just now ? | jarbie | |
05/9/2012 13:13 | 4screws - the price is low because it reflects the team performance since inception 9 years ago and before that in the name of British Biotech when unwarranted claims were made for the progress at that time. Look now at the works in progress and tell me what inspires you. If it was not for the consolidation the share price would be a fraction of a penny. One four hundredth of a price now, two one twentieth consolidations. If it was not for the RIs the company would have gone bust long before now. We have just reversed into AIM - not the right direction I fear. What else can we say - plenty, but that would be a waste of time. | jarbie | |
04/9/2012 21:05 | leading ladies you sure have...I cannot for the life of me work out why the price is so low and it certainly does not fill me with confidence going forward. | 4screws | |
04/9/2012 19:12 | Agree completely with last 2 postings. Only argument for I can think of is akin to share save schemes option price set 20% below share price at the time. Other thing to bear in my is we are talking about 45k of shares. If price didn't change would be hardly worth it. Mind you if it went up £1 would it still be worth it for those highly paid Directors ?? Just talked myself out of that argument ! | leadingladies |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions